<DOC>
	<DOC>NCT00578773</DOC>
	<brief_summary>The purpose of this study is to determine if an otic formulation is safe and effective in treating peri-operative tube otorrhea.</brief_summary>
	<brief_title>A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>6 months to 12 years old Diagnosed with recurrent acute otitis media or chronic otitis media with effusion Must be first set of ear tubes. Patient may not have had any other previous otologicrelated surgery. Ear tube may not be silver oxide, silver salt, ttype tube or longshafted tube Patient may not have existing perforation of the eardrum. Patient must not require another surgical procedure other than myringotomy and tube insertion. Patient may not be a menarchal female Diabetic patients are not eligible Patient may not have any disease or condition that would negatively affect the conduct of the study Patient may not require any other systemic antimicrobial therapy during the study. Patient must meet certain medication washouts to be eligible Analgesic use (other than acetaminophen) is not allowed Patient may not be predisposed to neurosensory hearing loss Other protocoldefined inclusion criteria may apply Age Other protocoldefined exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>ear tubes</keyword>
	<keyword>ear infection</keyword>
	<keyword>ear drops</keyword>
	<keyword>ear tube surgery</keyword>
	<keyword>acute otitis media</keyword>
</DOC>